Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Larimar Therapeutics
Biotech
Stanford president resigns—Chutes & Ladders
Stanford president resigns after internal investigation. Former AbbVie strategy chief to lead Neumora. BMS poaches Pfizer neuroscience exec.
Max Bayer
,
Gabrielle Masson
Jul 21, 2023 9:30am
Larimar's limbo finally ends as FDA removes clinical hold
Sep 14, 2022 9:20am
Larimar still in limbo as company preps response to FDA hold
Aug 12, 2022 8:47am
Larimar in limbo as FDA maintains clinical hold
Feb 15, 2022 10:05am
Larimar Therapeutics slapped with FDA clinical hold
May 26, 2021 7:10am